Calinao, Perlita B.
HRN: 05-49-01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/23/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/23/2023
03/02/2023
IV
4.5gms
Q6
CAP HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes